-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Financial Survey: Avalon GloboCare (ALBT) Vs. Its Rivals
Financial Survey: Avalon GloboCare (ALBT) Vs. Its Rivals
Avalon GloboCare (NASDAQ:ALBT – Get Rating) is one of 60 public companies in the "Management consulting services" industry, but how does it weigh in compared to its competitors? We will compare Avalon GloboCare to similar companies based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Avalon GloboCare and its competitors, as provided by MarketBeat.com.
Get Avalon GloboCare alerts:| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avalon GloboCare | 0 | 0 | 0 | 0 | N/A |
| Avalon GloboCare Competitors | 54 | 447 | 965 | 15 | 2.64 |
As a group, "Management consulting services" companies have a potential upside of 45.39%. Given Avalon GloboCare's competitors higher probable upside, analysts plainly believe Avalon GloboCare has less favorable growth aspects than its competitors.
Volatility & Risk
Avalon GloboCare has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Comparatively, Avalon GloboCare's competitors have a beta of 1.76, indicating that their average share price is 76% more volatile than the S&P 500.Profitability
This table compares Avalon GloboCare and its competitors' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Avalon GloboCare | -955.48% | -460.58% | -97.43% |
| Avalon GloboCare Competitors | -56.87% | -79.82% | -7.02% |
Valuation & Earnings
This table compares Avalon GloboCare and its competitors top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Avalon GloboCare | $1.39 million | -$9.09 million | -2.59 |
| Avalon GloboCare Competitors | $1.54 billion | $108.11 million | 13.68 |
Avalon GloboCare's competitors have higher revenue and earnings than Avalon GloboCare. Avalon GloboCare is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Insider and Institutional Ownership
0.9% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 41.3% of shares of all "Management consulting services" companies are owned by institutional investors. 64.0% of Avalon GloboCare shares are owned by insiders. Comparatively, 29.2% of shares of all "Management consulting services" companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Avalon GloboCare competitors beat Avalon GloboCare on 9 of the 10 factors compared.
Avalon GloboCare Company Profile
(Get Rating)
Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. It operates through the following segments: Real Property Operating, Medical Related Consulting Services, and Development Services & Sales of Developed Products. It offers regenerative medicine, cell-based immunotherapy, exosome technology, and rehabilitation medicine through Avalon Cell and Avalon Rehab platforms. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.
Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.
Avalon GloboCare (NASDAQ:ALBT – Get Rating) is one of 60 public companies in the "Management consulting services" industry, but how does it weigh in compared to its competitors? We will compare Avalon GloboCare to similar companies based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership.
阿瓦隆 GloboCare（NASDAQ：ALBT — 獲取評級）是「管理諮詢服務」行業的 60 家上市公司之一，但與競爭對手相比，它的重量如何？我們將根據其估值，風險，分析師建議，盈利能力，股息，收益和機構所有權的實力將 Avalon GloboCare 與類似公司進行比較。
Analyst Ratings
分析師評級
This is a breakdown of current ratings and recommmendations for Avalon GloboCare and its competitors, as provided by MarketBeat.com.
這是由 MarketBeat.com 提供的阿瓦隆環球保健及其競爭對手的當前評級和建議的細分。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avalon GloboCare | 0 | 0 | 0 | 0 | N/A |
| Avalon GloboCare Competitors | 54 | 447 | 965 | 15 | 2.64 |
| 銷售評級 | 保留評分 | 購買評級 | 強大的買入評級 | 評級分數 | |
| 阿瓦隆全球護理 | 0 | 0 | 0 | 0 | N/A |
| 阿瓦隆環球保健競爭對手 | 54 | 447 | 965 | 15 | 2.64 |
As a group, "Management consulting services" companies have a potential upside of 45.39%. Given Avalon GloboCare's competitors higher probable upside, analysts plainly believe Avalon GloboCare has less favorable growth aspects than its competitors.
作為一個集團，「管理諮詢服務」公司的潛在上升空間為 45.39％。鑑於阿瓦隆 GloboCare 的競爭對手可能較高的上行空間，分析師清楚地認為阿瓦隆 GloboCare 的增長方面比競爭對手不太有利。
Volatility & Risk
波動性和風險
Profitability
盈利
This table compares Avalon GloboCare and its competitors' net margins, return on equity and return on assets.
此表格比較 Avalon GloboCare 及其競爭對手的淨利潤率、股本回報率及資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Avalon GloboCare | -955.48% | -460.58% | -97.43% |
| Avalon GloboCare Competitors | -56.87% | -79.82% | -7.02% |
| 淨利潤 | 權益回報率 | 資產回報率 | |
| 阿瓦隆全球護理 | -955.48% | -460.58% | -97.43% |
| 阿瓦隆環球保健競爭對手 | -56.87% | -79.82% | -7.02% |
Valuation & Earnings
估值及收益
This table compares Avalon GloboCare and its competitors top-line revenue, earnings per share (EPS) and valuation.
此表格比較阿瓦隆 GloboCare 及其競爭對手的頂級收入，每股收益（EPS）和估值。
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Avalon GloboCare | $1.39 million | -$9.09 million | -2.59 |
| Avalon GloboCare Competitors | $1.54 billion | $108.11 million | 13.68 |
| 總收入 | 淨收入 | 市盈比率 | |
| 阿瓦隆全球護理 | 一百三十九萬元 | -909 萬美元 | -2.59 |
| 阿瓦隆環球保健競爭對手 | 十五億五千萬元 | 一億八百一十一萬元 | 13.68 |
Avalon GloboCare's competitors have higher revenue and earnings than Avalon GloboCare. Avalon GloboCare is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
阿瓦隆 GloboCare 的競爭對手擁有比阿瓦隆環球保險更高的收入和收益。Avalon GloboCare 的交易價格與收益比較低，這表明它目前比其行業中的其他公司更實惠。
Insider and Institutional Ownership
內幕和機構所有權
0.9% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 41.3% of shares of all "Management consulting services" companies are owned by institutional investors. 64.0% of Avalon GloboCare shares are owned by insiders. Comparatively, 29.2% of shares of all "Management consulting services" companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
阿瓦隆環球投資者的 0.9% 股份由機構投資者擁有。相比之下，所有「管理諮詢服務」公司的 41.3％ 股份由機構投資者擁有。64.0％ 的阿瓦隆 GloboCare 股份由內部人士擁有。相比之下，所有「管理諮詢服務」公司的股份 29.2％ 由內部人士擁有。強大的機構擁有權表明，大型資金經理，捐贈基金和對沖基金認為股票有望實現長期增長。
Summary
摘要
Avalon GloboCare competitors beat Avalon GloboCare on 9 of the 10 factors compared.
阿瓦隆 GloboCare 競爭對手在 10 個因素中的 9 個因素中擊敗了阿瓦隆 GloboCare。
Avalon GloboCare Company Profile
阿瓦隆環球保健公司簡介
(Get Rating)
(取得評分)
Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. It operates through the following segments: Real Property Operating, Medical Related Consulting Services, and Development Services & Sales of Developed Products. It offers regenerative medicine, cell-based immunotherapy, exosome technology, and rehabilitation medicine through Avalon Cell and Avalon Rehab platforms. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.
阿瓦隆 GloboCare 公司是一家控股公司，從事生物技術的發展和提供醫療服務。它通過以下部分運營：房地產運營，醫療相關諮詢服務以及開發產品的開發服務和銷售。它通過 Avalon Cell 和 Avalon 康復平台提供再生醫學，基於細胞的免疫療法，外泌體技術和康復醫學。該公司成立於七月 28, 2014 和總部設在弗里霍爾德, 新澤西州.
Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.
接收阿瓦隆環球關懷日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Avalon GloboCare 及相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧